Related Experiment Video
Updated: Apr 6, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Tackling virological failure in HIV-infected children living in Africa
Mohammad-Ali Jenabian1, Cecilia T Costiniuk2, Ralph-Sydney Mboumba Bouassa3
1a 1 Département des Sciences Biologiques et Centre de recherche BioMed, Université du Québec à Montréal (UQAM), Montreal, QC, Canada .
Insights
Drug resistance causes antiretroviral treatment (ART) failure in children with HIV, particularly in Africa. New strategies are crucial to improve ART effectiveness and overcome challenges in pediatric HIV management.
Area of Science:
- Pediatric infectious diseases
- HIV/AIDS research
- Global health
Background:
- Antiretroviral treatment (ART) failure in children with HIV is a major concern, especially in developing nations.
- Sub-Saharan Africa bears the highest global burden of pediatric HIV infections.
- Drug resistance significantly contributes to treatment failure in this vulnerable population.
Purpose of the Study:
- To systematically review the current status of ART failure in HIV-infected children in Africa.
- To identify key factors influencing ART failure, including timing of initiation and diagnostic criteria.
- To explore management strategies and future directions for minimizing ART failure rates.
Main Methods:
- A systematic literature search was conducted using PubMed.
- Publications from the last 10 years were included.
- Studies focused on pediatric populations in Africa, examining ART initiation, failure diagnosis, predictors, and management.
Main Results:
- Despite ART program scale-up in Africa, significant challenges persist in managing pediatric HIV.
- Drug resistance is a primary driver of ART failure in HIV-infected children.
- Current therapeutic and management strategies require enhancement to address existing obstacles.
Conclusions:
- Novel therapeutic and management strategies are urgently needed to combat ART failure in African children with HIV.
- Addressing drug resistance and optimizing ART protocols are critical for improving treatment outcomes.
- Continued research and implementation of innovative approaches are essential for minimizing ART failure rates.
Abstract:
Drug resistance in HIV-infected children is one of the main contributors to antiretroviral treatment (ART) failure, especially in developing countries. Sub-Saharan Africa has the largest burden of pediatric HIV infection in the world. Herein, we systematically review the current status of ART failure in HIV-infected African children. A literature search for publications within 10 years was performed through PubMed to identify relevant articles. Included studies examined the impact of timing of ART initiation, criteria for diagnosing therapeutic failure, predictors of therapeutic failure, management strategies and future directions to minimize failure rates in these pediatric populations. Although there is scale-up of ART programs in Africa, novel therapeutic and management strategies are needed to overcome current challenges.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Retroviruses
Viral Mutations

